Literature DB >> 18542007

Inflammation and metabolic disorders.

Mohamad Navab1, Nima Gharavi, Andrew D Watson.   

Abstract

PURPOSE OF REVIEW: Poor nutrition, overweight and obesity have increasingly become a public health concern as they affect many metabolic disorders, including heart disease, diabetes, digestive system disorders, and renal failure. Study of the effects of life style including healthy nutrition will help further elucidate the mechanisms involved in the adverse effects of poor nutrition. RECENT
FINDINGS: Unhealthy life style including poor nutrition can result in imbalance in our oxidation/redox systems. Lipids can undergo oxidative modification by lipoxygenases, cyclooxygenases, myeloperoxidase, and other enzymes. Oxidized phospholipids can induce inflammatory molecules in the liver and other organs. This can contribute to inflammation, leading to coronary heart disease, stroke, renal failure, inflammatory bowl disease, metabolic syndrome, bone and joint disorders, and even certain types of cancer.
SUMMARY: Our antioxidant and antiinflammatory defense mechanisms contribute to a balance between the stimulators and the inhibitors of inflammation. Beyond a point, however, these systems might be overwhelmed and eventually fail. High-density lipoprotein is a potent inhibitor of the formation of toxic oxidized lipids. High-density lipoprotein is also an effective system for stimulating the genes whose products are active in the removal, inactivation, and elimination of toxic lipids. Supporting the high-density lipoprotein function should help maintain the balance in these systems. It is hoped that the present report would elucidate some of the ongoing work toward this goal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542007     DOI: 10.1097/MCO.0b013e32830460c2

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  37 in total

1.  Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.

Authors:  Rosalinda Madonna; Yong-Jian Geng; Roberto Bolli; Gregg Rokosh; Peter Ferdinandy; Cam Patterson; Raffaele De Caterina
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

2.  IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b.

Authors:  Chunmei Shi; Lijun Zhu; Xiaohui Chen; Nan Gu; Ling Chen; Lu Zhu; Lei Yang; Lingxia Pang; Xirong Guo; Chenbo Ji; Chunmei Zhang
Journal:  J Interferon Cytokine Res       Date:  2014-01-15       Impact factor: 2.607

Review 3.  Prodrug strategies for targeted therapy triggered by reactive oxygen species.

Authors:  Jorge Peiró Cadahía; Viola Previtali; Nikolaj S Troelsen; Mads H Clausen
Journal:  Medchemcomm       Date:  2019-05-08       Impact factor: 3.597

Review 4.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

5.  Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Cheryl Stevens; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2011-01       Impact factor: 4.994

6.  Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.

Authors:  A Azhar; H M El-Bassossy
Journal:  J Endocrinol Invest       Date:  2014-11-21       Impact factor: 4.256

Review 7.  Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy.

Authors:  Mark D Peterson; Paul M Gordon; Edward A Hurvitz; Charles F Burant
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-21       Impact factor: 4.310

8.  Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid.

Authors:  Savita Khanna; Han-A Park; Chandan K Sen; Trimurtulu Golakoti; Krishanu Sengupta; Somepalli Venkateswarlu; Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

9.  The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor-induced hepatic lipotoxicity in mice.

Authors:  Yun Wang; Luyong Zhang; Xudong Wu; Emily C Gurley; Elaine Kennedy; Phillip B Hylemon; William M Pandak; Arun J Sanyal; Huiping Zhou
Journal:  Hepatology       Date:  2013-02-12       Impact factor: 17.425

10.  Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.